Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Peg Horn - Chief Operating Officer Mark Goldsmith - Chairman & Chief Executive Officer Steve Kelsey - President of R&D Jack Anders - Senior Vice President, Finance and Principal Accounting Officer Conference Call Participants Jonathan Chang - SVB Leerink Marc Frahm - Cowen & Company Operator Good day, ladies and gentlemen, and welcome to the Revolution Medicines Fourth Quarter and Ful ...